A Novel Hydrogen Sulfide Prodrug, <scp>SG</scp>1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients

A Novel Hydrogen Sulfide Prodrug, <scp>SG</scp>1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients

Summary Recent studies demonstrate robust molecular cross talk and signaling between hydrogen sulfide (H 2 S) and nitric oxide ( NO ). Heart failure ( HF ) patients are deficient in both H 2 S and NO , two molecules that are critical for cardiovascular homeostasis. A phase I clinical trial of a nove...

保存先:

書誌詳細
主要な著者:	David J. Polhemus, Zhen Li, Christopher B. Pattillo, Gabriel Gojon, Tony Giordano, Henry Krum
フォーマット:	Artigo
言語:	英語
出版事項:	2015
オンライン･アクセス:	https://doi.org/10.1111/1755-5922.12128 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1755-5922.12128
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

A Novel Hydrogen Sulfide Prodrug, SG1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients
著者:: Polhemus, David J., 等
出版事項: (2015)

SG1002 and Catenated Divalent Organic Sulfur Compounds as Promising Hydrogen Sulfide Prodrugs
著者:: Gabriel Gojon, 等
出版事項: (2020)

SG1002 and Catenated Divalent Organic Sulfur Compounds as Promising Hydrogen Sulfide Prodrugs
著者:: Gojon, Gabriel, 等
出版事項: (2020)

Hydrogen Sulfide in Biochemistry and Medicine
著者:: Predmore, Benjamin Lee, 等
出版事項: (2012)

Hydrogen Sulfide in Biochemistry and Medicine
著者:: Benjamin L. Predmore, 等
出版事項: (2012)

Hydrogen sulfide prodrugs—a review
著者:: Yueqin Zheng, 等
出版事項: (2015)

Evolution of Hydrogen Sulfide Therapeutics to Treat Cardiovascular Disease
著者:: Zhen Li, 等
出版事項: (2018)

Anti‐inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H(2)S donors in COVID‐19 therapy
著者:: Citi, Valentina, 等
出版事項: (2020)

Zofenopril Protects Against Myocardial Ischemia–Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability
著者:: Erminia Donnarumma, 等
出版事項: (2016)

Hydrogen sulfide, then nitric oxide and vasoprotection
著者:: Chappell, Mark C.
出版事項: (2018)

Zofenopril Protects Against Myocardial Ischemia–Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability
著者:: Donnarumma, Erminia, 等
出版事項: (2016)

Effects of A Novel Hydrogen Sulfide Prodrug in a Porcine_Model of Acute Limb Ischemia
著者:: Rushing, Amanda M., 等
出版事項: (2019)

Hydrogen Sulfide in Pharmacotherapy, Beyond the Hydrogen Sulfide-Donors
著者:: Zaorska, Ewelina, 等
出版事項: (2020)

Hydrogen Sulfide in Pharmacotherapy, Beyond the Hydrogen Sulfide-Donors
著者:: Ewelina Zaorska, 等
出版事項: (2020)

<scp>NOSH</scp>‐aspirin (<scp>NBS</scp>‐1120), a dual nitric oxide and hydrogen sulfide‐releasing hybrid, reduces inflammatory pain
著者:: Miriam M. Fonseca, 等
出版事項: (2015)

Microbial Regulation of Host Hydrogen Sulfide Bioavailability and Metabolism
著者:: Shen, Xinggui, 等
出版事項: (2013)

Microbial regulation of host hydrogen sulfide bioavailability and metabolism
著者:: Xinggui Shen, 等
出版事項: (2013)

Anti‐inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H<sub>2</sub>S donors in COVID‐19 therapy
著者:: Valentina Citi, 等
出版事項: (2020)

Measurement of plasma hydrogen sulfide in vivo and in vitro
著者:: Shen, Xinggui, 等
出版事項: (2011)

Measurement of plasma hydrogen sulfide in vivo and in vitro
著者:: Xinggui Shen, 等
出版事項: (2011)

Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability?
著者:: Whiteman, Matthew, 等
出版事項: (2009)

Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability?
著者:: Matthew Whiteman, 等
出版事項: (2009)

Hydrogen sulfide, nitric oxide, and neurodegenerative disorders
著者:: Panthi, Sandesh, 等
出版事項: (2018)

Hydrogen sulfide, nitric oxide, and neurodegenerative disorders
著者:: Sandesh Panthi, 等
出版事項: (2018)

Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part <scp>I</scp>. Biochemical and physiological mechanisms
著者:: Csaba Szabó, 等
出版事項: (2013)

Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part <scp>II</scp>. Pathophysiological and therapeutic aspects
著者:: Katalin Módis, 等
出版事項: (2013)

Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras
著者:: Kashfi, Khosrow, 等
出版事項: (2012)

The Role of Hydrogen Sulfide in Evolution and the Evolution of Hydrogen Sulfide in Metabolism and Signaling
著者:: Kenneth R. Olson, 等
出版事項: (2015)

Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras
著者:: Khosrow Kashfi, 等
出版事項: (2012)

Hydrogen Sulfide Oxidation by Sulfide Quinone Oxidoreductase
著者:: Landry, Aaron P., 等
出版事項: (2020)

Hydrogen Sulfide Oxidation by Sulfide Quinone Oxidoreductase
著者:: Aaron P. Landry, 等
出版事項: (2020)

A Fatal Case of Acute Hydrogen Sulfide Poisoning Caused by Hydrogen Sulfide: Hydroxocobalamin Therapy for Acute Hydrogen Sulfide Poisoning
著者:: Yuji Fujita, 等
出版事項: (2011)

Hydrogen sulfide poisoning
著者:: Burnett, W.W., 等
出版事項: (1978)

Hydrogen sulfide poisoning.
出版事項: (1978)

Hydrogen sulfide poisoning
著者:: Smith, Roger P.
出版事項: (1978)

Hydrogen Sulfide and Cancer
著者:: Mark R. Hellmich, 等
出版事項: (2015)

Hydrogen Sulfide Poisoning
著者:: Roger P. Smith, 等
出版事項: (1979)

Inhaled Hydrogen Sulfide
著者:: Gian Paolo Volpato, 等
出版事項: (2008)

Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent
著者:: Adrienne L. King, 等
出版事項: (2014)

Emergence of Hydrogen Sulfide as an Endogenous Gaseous Signaling Molecule in Cardiovascular Disease
著者:: Polhemus, David J., 等
出版事項: (2014)